Daiichi and MSD have voluntarily withdrawn the BLA in the US for their patritumab deruxtecan for treating non-small cell lung ...

The HSS has terminated a contract previously awarded to Moderna to help advance a vaccine candidate targeting bird flu.

Teos will look to distribute its cash reserves to shareholders, along with proceeds raised from selling pipeline assets.

Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...

Expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumour patients.

Eton Pharmaceuticals’ NDA for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...

Merck KGaA is filing for global regulatory approvals of pimicotinib after it met primary and secondary endpoints in a Phase ...

The EC has granted approval for the new subcutaneous (SC) formulation of Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) ...

Scynexis has resumed dosing of its Brexafemme (ibrexafungerp) drug in a Phase III trial after a 19-month clinical hold by the ...

PL logistics need to invest in new technology and upskilling programs to scale their cell and gene therapy services.